Health Robotics' i.v.STATION Robot Proven to be Almost Four Times Faster Than Intelligent Hospital Systems' RIVA
"While we still have room for improvement, I'm happy with i.v. STATION'sthroughput results in Europe and now in America, especially consideringRIVA's 15+ year head-start. Although i.v.STATION's revolutionary designreceived accolades globally, there was some skepticism about its throughputdue to IHS' speculative claims about i.v.STATION's alleged slow speed,attributing it to its low cost and small size. There is now incontrovertibleevidence that larger and more expensive is not faster, quite the contrary.Even at less than 20% of the cost and footprint of RIVA, i.v.STATION isalmost 4 times faster, proven by its 2.5 minute filling of an identical I.V.Admixture stated by IHS to take RIVA 9.5 minutes to fill. IHS' baselessclaims about i.v.STATION are now proven to be as much hype as their owndecades-oldB statements about RIVA being able to compound chemotherapy: manysales announcements with nameless chemo customers, but not a single hospitalpharmacy in the world actually using RIVA for chemo", stated Werner Rainer,Health Robotics' CEO.
The difference in throughput is not due to the speed of the robotic arms,as these settings are mostly irrelevant. The 7 minutes' speed gap between the2 robots is due to IHS' old engineering design choices that make the RIVArobot move back and forth performing a myriad of unnecessary tasks tomultiple locations, for instance not needed on i.v.STATION due to its smartcarrousels with integrated bar-code and digital imaging features. The onlydifferences in the use of IV consumables in these otherwise matching videotestimonials are: a) that RIVA spends time throwing away (wasting) ahalf-full diluent's IV bag and a wasted 60cc syringe [in contrast, no wastewith i.v.STATION], and b) that i.v.STATION automatically caps the syringewith a tamper-evident cap [for security and safety reasons] while RIVAutilizes a plain Kendall cap that is easily subject to tampering. For thisand other comparisons please visit:http://www.health-robotics.com/en/compare-products/
"Even though we still have a lot of work ahead of us in expanding to 40+planned 2010 installations of i.v.STATION, we are now confident that we: a)have the right design, cost, and R.O.I./value proposition; b) possess theability to expand the design concept, the ROI, and benefits to TPNs; and c)have changed the paradigm by asking hospital pharmacists why should they pay$1+ million for a RIVA robot that is 4 times slower, 5 times larger, 9 timesheavier, and 5 times more expensive than i.v.STATION", concluded Mr. Rainer.
For the official IHS' testimonial of RIVA's 9.5 minutes powderreconstitution performance, please visit:http://www.intelligenthospitals.com/media/recon/recon.htm. In the event thatIHS withdraws or changes the above web link based on these grosslyunfavorable results shared through this press release, please email us at:firstname.lastname@example.org, and we should be able to direct you to an alternateweb link so you can witness the video testimonial as originally and publiclyreleased by IHS. To view i.v.STATION's 2.5 minutes performance, please visit:http://www.health-robotics.com/en/solutions/i-v-station/
About Health Robotics:
Health Robotics is the undisputed global leading supplier oflife-critical intra-venous medication robots, providing healthcare facilitiesin 5 continents with robotics technology and software automation solutions.Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM)[non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding,powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteralnutrition] have and will greatly contribute to ease hospitals' growingpressures to improve patient safety, increase throughput and contain costs.Through the effective and efficient production of sterile, accurate,tamper-evident and ready-to-administer IVs, Health Robotics' solutions helphospitals eliminate life-threatening drug-exchange errors, decrease othertherapy oversights and sterility risks, work more efficiently, reduce wasteand controlled substances' diversion, and diminish the gap between risingpatient volume/acuity and scarce nursing and pharmacy staff. For moreinformation, please visit http://www.health-robotics.com
A Winnipeg TV Interview with IHS' CEO stating 11 installs of RIVA in 2008and 30 installs in 2009 (RIVA's real cumulative total achieved by 2010= 3units) and $1M price.B Am J Hosp Pharm 46(11): 2286-93 1989 For additional information, please contact: Health Robotics S.r.l. Gaspar G. DeViedma, Executive V.P., General Counsel, and Member of the Board of Directors Italy: +39-346-963-4934 USA: +1-609-980-7976 Canada: +1-289-470-1456 Malaysia: +60-321-848-223 email@example.com
SOURCE Health Robotics
You May Also Like